Home Cart Sign in  
Chemical Structure| 1533438-83-3 Chemical Structure| 1533438-83-3

Structure of TVB-3166
CAS No.: 1533438-83-3

Chemical Structure| 1533438-83-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TVB-3166 is an orally-available, reversible, potent, and selective FASN inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of TVB-3166

CAS No. :1533438-83-3
Formula : C24H24N4O
M.W : 384.47
SMILES Code : N#CC1=CC=C(C2CN(C(C3=CC(C4=NNC(C)=C4C)=C(C)C=C3C)=O)C2)C=C1
MDL No. :MFCD30534126
InChI Key :ICDQFUFDAFKCAX-UHFFFAOYSA-N
Pubchem ID :72947731

Safety of TVB-3166

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CALU-6 0.1 µM 3-4 weeks Inhibits soft agar colony growth EBioMedicine. 2017 Feb;16:51-62
22Rv1 1 µM 48 hours Inhibits β-tubulin mRNA expression EBioMedicine. 2017 Feb;16:51-62
Vero-E6 160-2.5 µM 20 hours To evaluate the inhibitory effect of TVB-3166 on SARS-CoV-2 infection, results showed that TVB-3166 significantly inhibited SARS-CoV-2 replication. Acta Pharm Sin B. 2022 Apr;12(4):1624-1635
Huh 7.5 160-2.5 µM 20 hours To evaluate the inhibitory effect of TVB-3166 on SARS-CoV-2 infection, results showed that TVB-3166 significantly inhibited SARS-CoV-2 replication. Acta Pharm Sin B. 2022 Apr;12(4):1624-1635
Hela-ACE-2 160-2.5 µM 20 hours To evaluate the inhibitory effect of TVB-3166 on SARS-CoV-2 infection, results showed that TVB-3166 significantly inhibited SARS-CoV-2 replication. Acta Pharm Sin B. 2022 Apr;12(4):1624-1635
LNCaP-LN3 prostate cancer cells 50 µM 24 hours To evaluate the effect of TVB-3166 on cell proliferation, the results showed that TVB-3166 significantly reduced cell viability. Cells. 2020 Nov 10;9(11):2447
Baf3 cells 100 nM 48 hours Validate the effect of FASN inhibition on c-Kit mutant signaling, showing upregulation of pS6 Biomedicines. 2025 Mar 3;13(3):619
Kasumi1 cells 100 nM 8 hours Evaluate the effect of FASN inhibition on c-Kit signaling, showing significant upregulation of pS6 Biomedicines. 2025 Mar 3;13(3):619

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
A/J mice MHV-S infection model Oral 30 mg/kg Once daily Evaluate the effect of TVB-3166 on survival and clinical symptoms in MHV-S infected mice J Lipid Res. 2022 Sep;63(9):100256
BALB/c nude mice Subcutaneous xenograft model Oral 60 mg/kg Once daily for approximately 5 weeks TVB-3166 significantly inhibited tumor growth and reversed gemcitabine resistance J Transl Med. 2024 Jan 13;22(1):55
BALB-c-nude mice CALU6 NSCLC xenograft model Oral gavage and intravenous injection 60 mg/kg TVB-3166 + 10 mg/kg paclitaxel Once daily TVB-3166, once every 4 days paclitaxel, until study termination Significantly enhanced anti-tumor efficacy, leading to tumor regression EBioMedicine. 2017 Feb;16:51-62

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.60mL

0.52mL

0.26mL

13.00mL

2.60mL

1.30mL

26.01mL

5.20mL

2.60mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories